Zeitschriftenartikel zum Thema „Conference (1926 : Philadelphia, Pa.)“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Conference (1926 : Philadelphia, Pa.)" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
O'Keefe, Thomas, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire et al. „Abstract PR008: Duration of endocrine treatment for DCIS impacts second events: Insights from a large registry of cases at two academic medical centers“. Cancer Prevention Research 15, Nr. 12_Supplement_1 (01.12.2022): PR008. http://dx.doi.org/10.1158/1940-6215.dcis22-pr008.
Der volle Inhalt der QuelleSmith, Randall S., Andrea Jewell, Evrosina Isaac und Jennifer M. Rohan. „Abstract B090: Relationship between medication adherence, psychosocial risk, and sociodemographic characteristics in pediatric cancer“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): B090. http://dx.doi.org/10.1158/1538-7755.disp22-b090.
Der volle Inhalt der QuelleCarter, Brian J., Tzuan A. Chen, Dalnim Cho, Lorna H. McNeill, Shahnjayla K. Connors und Lorraine R. Reitzel. „Abstract A099: Black church-goers who most recently sought cancer information from certain sources are less likely to have ever undergone colorectal cancer screening and thus less likely to benefit from early detection“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): A099. http://dx.doi.org/10.1158/1538-7755.disp22-a099.
Der volle Inhalt der QuelleLalonde, Chloe S., Jeffrey M. Switchenko, Madhusmita Behera, Mehmet A. Bilen, Taofeek K. Owonikoko, Colleen M. Lewis, Elise Hitron et al. „Abstract B085: Shifting sociodemographic characteristics of a phase 1 oncology clinical trial population at an NCI-designated Comprehensive Cancer Center in the Southeast in comparison to its catchment area“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): B085. http://dx.doi.org/10.1158/1538-7755.disp22-b085.
Der volle Inhalt der QuelleTelles, Victoria M., Mateo Banegas und David Strong. „Abstract B131: Social drivers of adverse health outcomes among cancer survivors“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 12_Supplement (01.12.2023): B131. http://dx.doi.org/10.1158/1538-7755.disp23-b131.
Der volle Inhalt der QuelleVasthu, Durango. „Global Supply Chain Management Conference“. International Journal of Risk and Contingency Management 1, Nr. 1 (Januar 2012): 64–65. http://dx.doi.org/10.4018/ijrcm.2012010105.
Der volle Inhalt der QuelleJohnson, Wenora Y. „Abstract IA002: How patient advocates can make a difference in their research advocacy efforts and contributions and why it's important“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): IA002. http://dx.doi.org/10.1158/1538-7755.disp22-ia002.
Der volle Inhalt der QuelleDrage, Michael G. „Abstract IA005: Artificial intelligence for breast pathology: Challenges and opportunities (and more challenges!)“. Cancer Prevention Research 15, Nr. 12_Supplement_1 (01.12.2022): IA005. http://dx.doi.org/10.1158/1940-6215.dcis22-ia005.
Der volle Inhalt der QuelleAshour, Ahmed M., Amro M. Al-Omari, Mohammad S. Bani Amer und Zaid R. Kamal. „Abstract A010: Insights into the Impact of Fanconi Anemia Repair Genes on Immunotherapy Response in Solid Tumors“. Cancer Research 84, Nr. 1_Supplement (09.01.2024): A010. http://dx.doi.org/10.1158/1538-7445.dnarepair24-a010.
Der volle Inhalt der QuelleSharma, Hari, Stephen Skaper und Aruna Sharma. „Conference Report: 7th Clinical Trials on Alzheimer’s Disease Annual Conference, Philadelphia, PA, USA Nov 20-22, 2014“. CNS & Neurological Disorders - Drug Targets 14, Nr. 1 (01.02.2015): 7–10. http://dx.doi.org/10.2174/1871527314666150130155536.
Der volle Inhalt der QuelleLeighow, Scott M., Haider Inam und Justin R. Pritchard. „Abstract B007: Design and construction of evolutionary-guided "selection gene drive" therapy“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B007. http://dx.doi.org/10.1158/1538-7445.evodyn22-b007.
Der volle Inhalt der QuelleDawson, Michelle R., und Deepraj Ghosh. „Abstract A002: Physical and metabolic aspects of therapy induced senescence and polyploidy in an evolving tumor microenvironment“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): A002. http://dx.doi.org/10.1158/1538-7445.agca22-a002.
Der volle Inhalt der QuelleWatson, Nyeema, und Jennifer Johnson Kebea. „All In: The Urban Mission“. Metropolitan Universities 31, Nr. 2 (20.07.2020): 3–6. http://dx.doi.org/10.18060/24223.
Der volle Inhalt der QuelleHockings, Helen, Michelle Lockley, Trevor Graham, Eszter Lakatos und Weini Huang. „Abstract B001: Developing adaptive therapy to suppress the evolution of treatment resistance in high-grade serous ovarian cancer“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B001. http://dx.doi.org/10.1158/1538-7445.evodyn22-b001.
Der volle Inhalt der Quellede Aragao Mendes, Adrianna Amaral, Hans Liu, Juhyung Woo, Kaushal Asrani, Avi Rosenberg, Pedram Argani und Tamara Lotan. „Abstract A019: Development and characterization of novel pre-clinical models of SFPQ-TFE3-driven renal cell carcinoma“. Cancer Research 83, Nr. 16_Supplement (15.08.2023): A019. http://dx.doi.org/10.1158/1538-7445.kidney23-a019.
Der volle Inhalt der QuelleZhuang, Xueqian, Simon Joost, Qing Wang, Melissa Blum, Selena Ding, Zhuxuan Li, Yingqian Zhan, Richard Koche, Emily Wong und Tuomas Tammela. „Abstract B019: Aging-induced reprogramming of the cell of origin defines lung cancer evolution“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): B019. http://dx.doi.org/10.1158/1538-7445.agca22-b019.
Der volle Inhalt der QuelleZhakula-Kostadinova, Nadja, Sejal Jain, Laura Byron, Matthew L. Meyerson und Alison M. Taylor. „Abstract B018: Investigating vulnerabilities associated with chromosome arm aneuploidy in cancer“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): B018. http://dx.doi.org/10.1158/1538-8514.synthleth24-b018.
Der volle Inhalt der QuelleAlfaro-Murillo, Jorge A., Krishna Dasari und Jeffrey P. Townsend. „Abstract B011: Detecting pairwise and higher-order antagonistic epistatic effects among somatic cancer genotypes to discover synthetic lethality“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): B011. http://dx.doi.org/10.1158/1538-8514.synthleth24-b011.
Der volle Inhalt der QuelleAndersson, Natalie, Adriana Mañas Nuñez, Kristina Aaltonen, Karin Hansson, Alexandra Seger, Katarzyna Radke, Javanshir Esfandyari, Daniel Bexell und David Gisselsson. „Abstract A011: Deciphering clonal evolution under chemotherapy in high-risk neuroblastoma using patient derived models“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): A011. http://dx.doi.org/10.1158/1538-7445.evodyn22-a011.
Der volle Inhalt der QuelleAvdieiev, Stanislav, Leticia Tordesillas, Omar Chavez Chiang, Zhihua Chen, Luiza Silva Simoes, Y. Ann Chen, Noemi Andor et al. „Abstract A017: In vivo tracking of clonal dynamics during UV-induced skin carcinogenesis“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): A017. http://dx.doi.org/10.1158/1538-7445.evodyn22-a017.
Der volle Inhalt der QuelleGardner, Andrea, Lan Zheng, Kennedy Howland, Chisom Iloegbunam, Patrik Barrera, Carolina De Santiago und Amy Brock. „Abstract B017: Homotypic cell-cell fusion in TNBC cells downregulates cancer testis antigen MAGEC2 and increases therapeutic sensitivity to paclitaxel and doxorubicin“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B017. http://dx.doi.org/10.1158/1538-7445.evodyn22-b017.
Der volle Inhalt der QuelleGatenbee, Chandler D., Ann-Marie Baker, Ryan O. Schenck, Maximilian Strobl, Jeffrey West, Mark Robertson-Tessi, Trevor A. Graham und Alexander R. A. Anderson. „Abstract B033: Immunosuppressive niche engineering at the onset of human colorectal cancer“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B033. http://dx.doi.org/10.1158/1538-7445.evodyn22-b033.
Der volle Inhalt der QuelleGiersch, Rachael M., Marisa A. Yonemitsu, Samuel F. M. Hart und Michael J. Metzger. „Abstract A023: Progression and regression dynamics of bivalve transmissible neoplasia in the soft-shell clam (Mya arenaria) after both natural and experimental exposure“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): A023. http://dx.doi.org/10.1158/1538-7445.evodyn22-a023.
Der volle Inhalt der QuelleBraxton, Alicia M., Ashley Kiemen, Rachel Karchin, Yuchen Jiao, Pei-Hsun Wu, Ralph H. Hruban, Denis Wirtz und Laura D. Wood. „Abstract B027: Three-dimensional genomic analysis of human pancreatic intraepithelial neoplasia (PanIN) reveals striking multifocality and genetic heterogeneity“. Cancer Research 82, Nr. 22_Supplement (15.11.2022): B027. http://dx.doi.org/10.1158/1538-7445.panca22-b027.
Der volle Inhalt der QuelleMason, Frank M., Anteneh T. Tebeje, Emily S. Kounlavong, Rashmi Dahiya, Logan Vlach, Tiffany Guess, Ruhee Dere et al. „Abstract B016: SETD2 safeguards the genome against isochromosome formation“. Cancer Research 83, Nr. 16_Supplement (15.08.2023): B016. http://dx.doi.org/10.1158/1538-7445.kidney23-b016.
Der volle Inhalt der QuelleMiyano, Masaru, Rosalyn W. Sayaman, Parijat Senapati, Stefan Hinz, Victoria E. Seewaldt, Dustin Schones und Mark A. LaBarge. „Abstract A003: Integrating noise into a signal: Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): A003. http://dx.doi.org/10.1158/1538-7445.agca22-a003.
Der volle Inhalt der QuelleModiano, Jaime F., Ashley J. Schulte, Taylor A. DaPauw, Ali Khammanivong, Jong H. Kim, Aaron L. Sarver, Gary R. Cutter, Eric Lindquist und Kelly M. Makielski. „Abstract A004: Identification and characterization of the cancer permissive environment in companion dogs“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): A004. http://dx.doi.org/10.1158/1538-7445.agca22-a004.
Der volle Inhalt der QuelleZhang, Yuxia, Virginia Ojeda, Xiaobo Wang, Ken Dunner, Filippo Giancotti, Hao Zhou, Jonathan Hernandez und Steven Q. Xu. „Abstract A029: Merlin/NF2 inhibits pancreatic cancer metastasis by activation of AMPK-dependent autophagic degradation of p62“. Cancer Research 84, Nr. 3_Supplement_2 (01.02.2024): A029. http://dx.doi.org/10.1158/1538-7445.canevol23-a029.
Der volle Inhalt der QuelleOlsen, Sarah Naomi, Bryn Anderson, Charles Hatton, Rinath Jeselsohn, Myles Brown, Eneda Toska und Scott Armstrong. „Abstract A025: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): A025. http://dx.doi.org/10.1158/1538-8514.synthleth24-a025.
Der volle Inhalt der QuelleDeng, Qiyun, Mehdi Amiri, Anastasija Ana Piric, Yasaman Bagherian, Zilan Li, Sidong Huang, Michael Pollak und Nahum Sonenberg. „Abstract A014: Inhibiting eIF4E phosphorylation sensitizes triple-negative breast cancer to CDK4/6 inhibition“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): A014. http://dx.doi.org/10.1158/1538-8514.synthleth24-a014.
Der volle Inhalt der QuelleChen, Richard J., Drew F. K. Williamson, Ming Y. Lu, Tiffany Y. Chen, Jana Lipkova, Muhammad Shaban und Faisal Mahmood. „Abstract A007: Racial disparities bias oncology AI models“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): A007. http://dx.doi.org/10.1158/1538-7755.disp22-a007.
Der volle Inhalt der QuelleShokat, Kevan M. „Abstract IA08: Direct covalent inhibitors of mutant K-Ras“. Molecular Cancer Research 21, Nr. 5_Supplement (01.05.2023): IA08. http://dx.doi.org/10.1158/1557-3125.ras23-ia08.
Der volle Inhalt der QuelleHahn, William C. „Abstract IA25: Systematic interrogation of KRAS function“. Molecular Cancer Research 21, Nr. 5_Supplement (01.05.2023): IA25. http://dx.doi.org/10.1158/1557-3125.ras23-ia25.
Der volle Inhalt der QuelleLahtinen, Alexandra, Kari Lavikka, Yilin Li, Sanaz Jamalzadeh, Anni Virtanen, Rainer Lehtonen, Olli Carpén et al. „Abstract A010: Integration of clonal composition and tumor heterogeneity reveals novel evolutionary states and intervention targets in ovarian cancer“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): A010. http://dx.doi.org/10.1158/1538-7445.evodyn22-a010.
Der volle Inhalt der QuelleHirosue, Shoko, Jianfeng Ge, Leticia Castillon, Paulo Rodrigues, Dóra Bihary, Alyson Speed, Ludovic Wesolowski et al. „Abstract A015: Injury-associated transcriptional state transitions in early renal carcinogenesis“. Cancer Research 83, Nr. 16_Supplement (15.08.2023): A015. http://dx.doi.org/10.1158/1538-7445.kidney23-a015.
Der volle Inhalt der QuelleChen, Guangbo, Hong Zheng, Yael Rosenberg-Hasson, Saron Araya, Cindy Padilla, Kavita Sarin, Cornelia L. Dekker et al. „Abstract A014: Cytokines surge in the blood years prior to a cancer diagnosis in elderly individuals“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): A014. http://dx.doi.org/10.1158/1538-7445.agca22-a014.
Der volle Inhalt der QuelleLi, Peng, Yuanli Zhen, Chiho Kim, Zhengshuai Liu, Jianwei Hao, Heping Deng, Hejun Deng et al. „Abstract B023: Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): B023. http://dx.doi.org/10.1158/1538-8514.synthleth24-b023.
Der volle Inhalt der QuelleMilne, Julia V., Ebtihal Mustafa, Kenji Fujihara, Eric Kusnadi, Anna Trigos, Niko Thio, Maree Pechlivanis et al. „Abstract A006: Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): A006. http://dx.doi.org/10.1158/1538-8514.synthleth24-a006.
Der volle Inhalt der QuelleArafeh, Rand, Laura Chang, Lydia Sawyer, Helen Wang, James McFarland, Joshua Dempster, Peter DeWeirdt, John Doench und William C. Hahn. „Abstract B015: Combinatorial genetic screens to map synthetic lethal interactions and identify new cancer drug targets in KRAS mutant cancers“. Molecular Cancer Therapeutics 23, Nr. 6_Supplement (10.06.2024): B015. http://dx.doi.org/10.1158/1538-8514.synthleth24-b015.
Der volle Inhalt der QuelleYeh, Jen Jen. „Abstract IA011: Precision oncology approaches in pancreatic cancer“. Cancer Research 82, Nr. 22_Supplement (15.11.2022): IA011. http://dx.doi.org/10.1158/1538-7445.panca22-ia011.
Der volle Inhalt der QuelleMousseau, Richard J. „Abstract IA018: “Pursuing Wicozani for the Oceti Sakowin”: Reducing cancer disparities among AI/AN in the Great Plains“. Cancer Epidemiology, Biomarkers & Prevention 32, Nr. 1_Supplement (01.01.2023): IA018. http://dx.doi.org/10.1158/1538-7755.disp22-ia018.
Der volle Inhalt der QuelleLehman, Connie. „Abstract IA022: Imaging tools for DCIS: Past, present and future“. Cancer Prevention Research 15, Nr. 12_Supplement_1 (01.12.2022): IA022. http://dx.doi.org/10.1158/1940-6215.dcis22-ia022.
Der volle Inhalt der QuellePolyak, Kornelia. „Abstract IA035: DCIS to IDC progression - a key step of immune escape“. Cancer Prevention Research 15, Nr. 12_Supplement_1 (01.12.2022): IA035. http://dx.doi.org/10.1158/1940-6215.dcis22-ia035.
Der volle Inhalt der QuelleBar-Sagi, Dafna. „Abstract IA21: Immune rewiring of mutant Ras tumors: Mechanisms and translational implications“. Molecular Cancer Research 21, Nr. 5_Supplement (01.05.2023): IA21. http://dx.doi.org/10.1158/1557-3125.ras23-ia21.
Der volle Inhalt der QuelleRobertson-Tessi, Mark, Joel Brown, Maria Poole, Kimberly Luddy, Andriy Marusyk, Jill Gallaher, Jeffrey West et al. „Abstract B006: Evolutionary Tumor Board: Implementing dynamic personalized therapy using evolutionary theory and mathematical modeling for clinical decision support“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B006. http://dx.doi.org/10.1158/1538-7445.evodyn22-b006.
Der volle Inhalt der QuelleAhmed, Atique U., Jack M. Shireman, Fatemeh Atash, Gina Lee, Eunus S. Ali, Miranda R. Saathoff, Cheol H. Park et al. „Abstract B034: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): B034. http://dx.doi.org/10.1158/1538-7445.evodyn22-b034.
Der volle Inhalt der QuelleChalloner, Benjamin R., Andrew Woolston, David Lau, Marta Buzzetti, Louise J. Barber, Tom Lund, Harold B. Sansano et al. „Abstract A002: Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer“. Cancer Research 82, Nr. 10_Supplement (15.05.2022): A002. http://dx.doi.org/10.1158/1538-7445.evodyn22-a002.
Der volle Inhalt der QuelleMadrigal, Ariel, Minjun Kim, Adrien Osakwe, Tianyuan Lu, Zohreh Mehrjoo, Elham Moslemi, Rick Farouni et al. „Abstract B011: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomas“. Cancer Research 83, Nr. 16_Supplement (15.08.2023): B011. http://dx.doi.org/10.1158/1538-7445.kidney23-b011.
Der volle Inhalt der QuelleBorges, Gabriel Alvares, Angelo Jose Guilatco, Christine M. Hachfeld, Ming Ruan, Sonya Royzenblat, Ming Xu, Claire M. Edwards et al. „Abstract B020: Pre-malignant plasma cells exhibit a senescence-like phenotype and accumulation of transposable elements“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): B020. http://dx.doi.org/10.1158/1538-7445.agca22-b020.
Der volle Inhalt der QuelleLan, Tuo, Mei Wang, AnnaLynn M. Williams, Matthew J. Ehrhardt, Emily R. Finch, Jennifer Q. Lanctot, Shu Jiang et al. „Abstract B004: Sugar Intake and premature aging in adult survivors of childhood cancer in the St. Jude Lifetime (SJLIFE) Cohort“. Cancer Research 83, Nr. 2_Supplement_1 (15.01.2023): B004. http://dx.doi.org/10.1158/1538-7445.agca22-b004.
Der volle Inhalt der Quelle